NCT01191567

Brief Summary

Wounds have long been a source of suffering for unfortunate victims and in recent years new complementary methods have been developed in areas where traditional wound treatment has been insufficient. Treating wounds with negative pressure, Vacuum assisted closure® \[VAC\], is a relatively new method of treatment and knowledge about its effect on patients is limited. Earlier studies haven't been able to answer the question about which groups of patients that are in most favour of the treatment and what impact the treatment has on the patient's quality of life. It is important with further research since an effective and mild wound treatment can decrease suffering and increase quality of life for the patient. Wound treatment that does not lead to an achieved treatment goal can lead to a risk for the patient and should be avoided. The project consists of 4 part studies: Study 1 and 2 are chart review studies of a consecutive series of patients treated with VAC at Södersjukhuset during a 3 year period. The patients are described on the basis of medical, surgical and demographical factors. Outcome is treatment results and risk factors for a treatment failure. Study 3 and 4 are clinical randomised studies with the aim of studying whether treatment with VAC provides a faster and more effective healing of acute and postoperative wounds, and in what way the treatment affect the quality of life and pain of the patients, compared to conventional treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 31, 2010

Completed
1 day until next milestone

Study Start

First participant enrolled

September 1, 2010

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

November 17, 2017

Status Verified

November 1, 2017

Enrollment Period

1.8 years

First QC Date

August 26, 2010

Last Update Submit

November 15, 2017

Conditions

Keywords

acute woundspostoperative wounds

Outcome Measures

Primary Outcomes (3)

  • treatment results

    successfully treated or non-successfully treated

    2 weeks

  • wound size

    meassured with Visitrak

    2 weeks

  • Quality of life

    meassured with EQ-5D form and a diary with content analysis

    2 weeks

Secondary Outcomes (2)

  • Number of Participants with Adverse Events as a Measure of Safety and Tolerability

    2 weeks

  • costs for treatment

    2 weeks

Study Arms (2)

Conventional treatment

ACTIVE COMPARATOR
Procedure: Conventional treatment

VAC treatment

EXPERIMENTAL
Procedure: VAC treatment

Interventions

VAC treatmentPROCEDURE

wound treatment with VAC-therapy

VAC treatment

wound treatment with conventional treatment according to the hospitals local routines

Conventional treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • acute wounds with substance defect after primary suture demanding further treatment or wounds not primary sutured
  • wounds with osteosynthesis, bone or tendon visual regardless wound size
  • postoperative infections with wound and substance defect demanding further treatment.
  • fasciotomy on extremity

You may not qualify if:

  • wound size \< 2 cm and depth \< 1 cm
  • pressure ulcers, open abdomen and chronic ulcers
  • patients with dementia or mental illness so severe that participation in the study is impossible
  • patients non in command of the swedish language
  • ongoing treatment with warfarin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Södersjukhuset

Stockholm, 11883, Sweden

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
RN, PhD

Study Record Dates

First Submitted

August 26, 2010

First Posted

August 31, 2010

Study Start

September 1, 2010

Primary Completion

July 1, 2012

Study Completion

July 1, 2012

Last Updated

November 17, 2017

Record last verified: 2017-11

Locations